Timothy D. Mastro, MD, DTM&H is Chief Science Officer at FHI 360, Durham, North Carolina. He is also Adjunct Professor of Epidemiology in the Gillings School of Global Public Health, University of North Carolina at Chapel Hill. He oversees FHI 360’s research and science-based programs conducted in the United States and through FHI 360’s offices in 50 countries around the world. Dr. Mastro joined FHI 360 in 2008 following 20 years in scientific leadership positions at the US Centers for Disease Control and Prevention (CDC). His work has addressed research and programs on HIV treatment and prevention, TB, STIs and reproductive health, including serving on the scientific management committee for the ECHO randomized clinical trial investigating HIV acquisition risk and benefits for three contraceptive methods among women in Africa.
Findings from the ECHO trial led to an increased focus in HIV prevention in family planning programs. Here's what else needs to happen in the COVID-19 context.
chat_bubble0 Commentvisibility52945 Views
Listen to “Inside the FP Story”
Grab a cup of coffee or tea and listen in on honest conversations with family planning program experts around the world as they share what has worked in their settings — and what to avoid — in our podcast series, Inside the FP Story.
Click on the image above to visit the podcast page or on your preferred provider below to listen to Inside the FP Story.